Company Filing History:
Years Active: 2005-2007
Title: Ralph M Ellison: Innovator in Neoplastic Disease Treatment
Introduction
Ralph M Ellison is a notable inventor based in Palm Beach, FL (US), recognized for his contributions to the field of biopharmaceuticals. He holds a total of five patents, focusing primarily on innovative treatments for neoplastic diseases. His work has significant implications for the medical community, particularly in oncology.
Latest Patents
Ellison's latest patents include compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds. This invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound, or ionic solution to treat tumors of epithelial tissue, connective tissue, central nervous system, lymphoid tissue, hematopoietic cells, and tumors associated with oncogenic viruses. This invention also encompasses the treatment of hematopoietic disorders in mammals by the administration of one or more arsenic compounds to said mammal. Furthermore, the arsenic compounds may be used to treat metastatic neoplastic diseases.
Career Highlights
Ellison is currently associated with Polarx Biopharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatment options for patients suffering from various forms of cancer.
Collaborations
Some of his notable coworkers include Fred H Mermelstein and Fred H Marmelstein, who contribute to the collaborative efforts in the research and development of innovative treatments.
Conclusion
Ralph M Ellison's contributions to the field of biopharmaceuticals, particularly in the treatment of neoplastic diseases, highlight his role as a significant inventor. His innovative approaches and collaborations continue to pave the way for advancements in medical treatments.